The Uromigos Episode 162: Debate—Adjuvant Nivolumab for Bladder Cancer

By The Uromigos - Last Updated: March 14, 2022

Matt Galsky and Tom Powles take the FDA and EMA approach respectively concerning adjuvant nivolumab for bladder cancer.

Post Tags:Uromigos-Bladder CancerUromigos-Debate
Advertisement
Advertisement